BeStock  
Markets › Compare › IOVA vs MONOY

IOVA vs MONOY

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
IOVA · Iovance Biotherapeutics$14.15 ▼ 0.46%
MONOY · MonotaRO (ADR)$13.22 ▲ 1.61%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

38208377547716Oct 7, '25Apr 7, '26Oct 5, '26
  • IOVA +549.1%
  • MONOY -6.6%

Head to head

MetricIOVAMONOY
Price$14.15$13.22
Change today▼ 0.46%▲ 1.61%
Market cap$6.41B$6.41B
Return, 3 months+225.3%+11.2%
Return, year to date+418.3%-16.8%
Return, 1 year+540.3%-8.4%
P/E (TTM)-20.528.1
P/B8.78.5
P/E percentile vs own 5y––
Dividend yield–1.76%
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price––
Analyst buy share––
RSI (14)7962
30-day volatility92.4%37.6%
Max drawdown, 1 year-39.0%-34.9%
Trend readStrong uptrendStrong uptrend
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • IOVA is the largest of the group by market value.
  • IOVA has returned the most over the past year.
  • IOVA carries the lowest trailing P/E.
  • MONOY has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top